2Pol S,Nalpas B,Driss F,et al.Multicenter study group Efficacy and limitations of a specific immunotherapy in chronic hepatitis B [J] .J Hepatol,2001,34(6):17-21. 被引量：1
3Lau CK,Carman WF,Locarmin SA ,et al.Treatment of chromic hepatitis B virus infection:an Asia-Pacific perspective [J] .J Gastroenterol Hepatol,1999,14(1):3-12. 被引量：1
5Kakimi K,Lane TE,Chisari FV,et al.Cutting edge:Inhibitian of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver [J]. J Imnunol,2001,167(12):6701-6705. 被引量：1
3[10]Davis HL, Schirmbeck R, Reimann J, et al. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxie T lymphocyte response to the hepatitis B envelope protein [J]. Hum. Gene Ther. 1995, 6:1447～ 1456. 被引量：1
4[11]Stanislas Poi,et al. Effeicacy and limitations of a specific immunotherapy in chronic hepatitis B[J].J. of hepatology2001,34:917～921. 被引量：1
5[12]Michel M-L, Davis HL, Schleef M, et al. DNA-mediated immunization to the hepatitis B surface antigen in mice:aspects of the humoral response mimic hepatitis B viral infection in humans[J]. Proc Natl Acad Sci U.S.A,1995,92:5307～5311. 被引量：1
6[13]Pol S, Nalpas, Driss F, et al. Efficacy and limitations of a specific Immunotherapy In chronic hepatitis B [J]. Hepatol,2001, 34: 917～921. 被引量：1
7[14]M.L.Michel,et al. Immunothrapy of chronic hepatitis B by anti HBV vaccine :from present to future [J] .vaccine,2001,19: 2395～2399. 被引量：1
8[15]Olivier B.E.et al. Peptide vaccines against hepatitis B virus:from animal model to human studies[J]. Molecular Immunology, 2001,38:457～465. 被引量：1
9[1]Maria-Chrisina J, et al. Immunology of hepatitis B infection[J]. the lancet Infections Diseas, 2002,(2). 被引量：1
10[2]Fazle Akabar. et al. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: Vaccine induce activation of antigen presenting dendritic cells [J]. Hepatology 1999,30:755 ～ 764. 被引量：1
3Zeng Weiguang,Gauci Sonja,Ghosh Souravi,et al.Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH[J].Vaccine,2005,23:4427-4435. 被引量：1
4Vitiello Antonella,Ishioka Glenn,Grey Howard M,et al.Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection I.Induction of a primary cytotoxic T lymphocyte response in humans[J].J.Clin Invest,1995,95:341-349. 被引量：1
5BenMohamed Lbachir,Wechsler Steven L,Nesburn Anthony B.Lipopeptide vaccines-yesterday,today,andtomorrow[J].The LANCET Infectious Diseases,2002,2:425-431. 被引量：1
6Zhu Xiaoming,Thomas V,Gras-Masse Hélène,et al.Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity[J].Eur J Immunol,2004,34(11):3102-3114. 被引量：1
7Gras-Masse Hélène.Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxlc T cell responses in randomly selected populations[J].Moleoalar Immunology,2001,38:423-431. 被引量：1
8Tsunoda Ikuo,Sette Alessandro,Fujinami Robert S,et al.Lipopeptide particles as the immunologically active component of CTL inducing vaccines[J].Vaccine,1999,17(7-8):675-685. 被引量：1
9Hopp Thomas P.Immunogenicity of a synthetic HBsAg peptide:enhancement by conjugation to a fatty acid carrier[J].Mol Immunol,1984,21:13-16. 被引量：1
10Livinston Brian D,Crimi Crimi,Grey Howard M,et al.The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection[J].J Immunol,1997,159(3):1383-1392. 被引量：1
